Douglass Winthrop Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$11K | – | 261 |
|
|
2019
Q2 | $11K | Hold |
10,000
| – | – | ﹤0.01% | 258 |
|
|
2019
Q1 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 240 |
|
|
2018
Q4 | $9K | Sell |
10,000
-1,430
| -13% | -$1.29K | ﹤0.01% | 243 |
|
|
2018
Q3 | $23K | Hold |
11,430
| – | – | ﹤0.01% | 252 |
|
|
2018
Q2 | $21K | Hold |
11,430
| – | – | ﹤0.01% | 286 |
|
|
2018
Q1 | $27K | Hold |
11,430
| – | – | ﹤0.01% | 268 |
|
|
2017
Q4 | $21K | Hold |
11,430
| – | – | ﹤0.01% | 239 |
|
|
2017
Q3 | $28K | Hold |
11,430
| – | – | ﹤0.01% | 248 |
|
|
2017
Q2 | $31K | Hold |
11,430
| – | – | ﹤0.01% | 242 |
|
|
2017
Q1 | $34K | Hold |
11,430
| – | – | ﹤0.01% | 241 |
|
|
2016
Q4 | $36K | Hold |
11,430
| – | – | ﹤0.01% | 238 |
|
|
2016
Q3 | $39K | Hold |
11,430
| – | – | ﹤0.01% | 240 |
|
|
2016
Q2 | $26K | Sell |
11,430
-5,715
| -33% | -$13K | ﹤0.01% | 235 |
|
|
2016
Q1 | $43K | Sell |
17,145
-1,440
| -8% | -$3.61K | ﹤0.01% | 220 |
|
|
2015
Q4 | $61K | Hold |
18,585
| – | – | ﹤0.01% | 228 |
|
|
2015
Q3 | $45K | Buy |
+18,585
| New | +$45K | ﹤0.01% | 232 |
|